Every year, a health care think tank called the Lown Institute ranks the 10 worst examples of "profiteering and dysfunction" ...

Jack Danilkowicz appointed as Chief Commercial Officer; bringing extensive experience successfully planning and executing commercial strategies ...

That was my prediction at the start of 2024, and that very much ended up being the case by the end of the year. But the Street might have overdone the selling on Amgen. While MariTide is being ...

“I am honored to become the next Chairman of the Board of Directors of Context, where I expect to leverage my experience advising ... acquisition of Horizon by Amgen, Inc. in 2023.

“I am honored to become the next Chairman of the Board of Directors of Context, where I expect to leverage my experience advising ... and its $28 billion acquisition by Amgen in 2023.

The Tax Cuts and Jobs Act of 2017 reconfigured the tax code. Did it also enable a pharmaceutical giant to invest in Wake ...

We recently compiled a list of the 7 Cheap Quarterly Dividend Stocks to Invest in. In this article, we are going to take a ...

In a report released today, Tim Anderson from Bank of America Securities reiterated a Sell rating on Amgen (AMGN – Research Report), with a ...

As Sandoz gears up to launch one of the most anticipated biosimilars of the year, the company could face near-term competition thanks to a new agreement between Amgen and Celltrion. Late last week ...

Amgen Inc. closed 18.42% short of its 52-week high of $346.85, which the company achieved on July 25th.